GLOBOCAN 2012 estimates 14.1 million new cancer cases and 8.2 million cancer-related
deaths worldwide. Cancer is rapidly becoming a major public health concern in India as …

The effective clinical use of the three generation platinum anticancer drugs, cisplatin,
carboplatin, and oxaliplatin, has sparked interest in metallodrugs; however, drug resistance …

For some cancer subtypes, such as triple-negative breast cancer, there are no specific
therapies, which leads to a poor prognosis associated with invasion and metastases …

Metal-based compounds have emerged as a novel strategy to improve our arsenal of
medicines. Among these compounds, carbon monoxide donor agents have been developed …

The use of natural products as potential ligands has been explored as a strategy in the
development of metal-based chemotherapy. Since ruthenium complexes are promising …

The organometallic arene ruthenium complexes are rapidly advancing. In particular, the
organoruthenium complexes of the type [(η6-arene) Ru (X)(Y)(Z)] have attracted increasing …

Herein, the development of ruthenium complexes as potential apoptosis inducers, as well as
their underlying mechanism has been reviewed. In recent years, various ruthenium …

Peritoneal carcinomatosis is considered as a potentially lethal clinical condition, and the
therapeutic options are limited. The antitumor effectiveness of the [Ru (l-Met)(bipy)(dppb)] …

Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry
Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry Mini …

Ruthenium (II)/benzonitrile complexes have demonstrated promising anticancer properties.
Considering that there are no specific therapies for treating sarcoma, we decided to evaluate …